Keywords: Drug-induced liver injury; Hepatotoxicity; Gender differences; Drug property; Spontaneous adverse event reporting system; Liver events, and pharmacovigilance; DILI; drug-induced liver injury; DILIN; drug-induced liver injury network; HC; hepatocellular; C
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Clinical trial; Pilot; Training concept; Pharmacokinetic; Pharmacodynamic; Feasibility; ACE; Angiotensin-converting-enzyme; Cmax; maximum serum concentration; ELISA; Enzyme-linked immunosorbent assay; EMA; European Medicines Agency; EU; European Union; FD
Keywords: pharmacokinetics; obesity; pediatrics; proton pump inhibitors; AE; Adverse event; AUC; Area under the concentration time curve; AUCinf; AUC from time zero to infinity; AUClast; AUC from time zero to the time of the last measurable concentration; BMI; Body
Keywords: diuresis; furosemide; heart failure; pharmacokinetics; subcutaneous; ANOVA; analysis of variance; AUC; area under the curve; AUCâ; plasma concentration to infinity; AUClast; last measurable plasma concentration; CI; confidence interval; Cmax; peak plasm
Keywords: AIDS; acquired immunodeficiency syndrome; AUC; area under the plasma concentration versus time curve of NVP in absence of NT; AUCI; area under the plasma concentration versus time curve of NVP in presence of NT; AUCratio; ratio between AUCI and AUC (AUCI/
Keywords: ABCB1; gene coding the efflux transporter P glycoprotein; AUC; area under the concentration time curve; BPAR; biopsy proven acute rejection; C0; residual whole blood tacrolimus concentration; C24h; whole blood tacrolimus concentration at the end of the 24
Keywords: AE; adverse event; AUC; area under the curve; CI; confidence interval; Cmax; maximum concentration; HCC; hepatocellular carcinoma; HR; hazard ratio; OS; overall survival; PK; pharmacokinetic; PVA; polyvinyl alcohol; TTP; time to progression; W/O; water-in
Keywords: ADME; absorption, distribution, metabolism and excretion; AUC; area under the blood/plasma concentration time curve; BMDL; lower 95% confidence limit of the benchmark dose; Cmax; maximum blood/plasma concentration; NOAEL; no-observed-adverse-effect-level;
Keywords: Carbohydrate digestion; Gastrointestinal model; Glycemic response; In vitro-in silico prediction; Validation versus human studies; Glycemic food product; bw; body weight; Cmax; maximum concentration (blood glucose); HOMA; homeostatic model assessment (
Keywords: ABC; ATP-binding casette; aCSF; artificial cerebrospinal fluid; AP; anterior-posterior; aPPF; artificial peripheral perfusion fluid; AUC; area under the curve; BBB; blood-brain barrier; Cmax; maximum concentration; DMSO; dimethyl sulfoxide; DV; dorso-vetr
Keywords: anti-infectives; bioavailability; clinical pharmacokinetics; formulation; oral absorption; pharmacokinetics; HCV; hepatitis C virus; GT; genotype; DAA; direct-acting antiviral; RBV; ribavirin; GLE; glecaprevir; PIB; pibrentasvir; Cmax; maximum plasma conc
Keywords: ABD3; albumin-binding domain 3; ACN; acetonitrile; AUC; area under the curve; BA; bioavailability; cAMP; cyclic adenosine monophosphate; CHO; Chinese hamster ovary; DIEA; diisopropyl ethylene diamine; Cmax; peak plasma concentration; CLp; plasma clearance
Keywords: Immunocytochemistry; Leaf traits; Rupestrian field; Water relations; CW; cell walls; LWU; leaf water uptake; GalA; galacturonic acid; HGA; homogalacturonans; RG-I; rhamnogalacturonans I; RG-II; rhamnogalacturonans II; Cmax; maximum water content; k; leaf
Keywords: Gastric emptying; Idiopathic pulmonary fibrosis; Pharmacokinetics; Pirfenidone; AE; adverse event; AUC0-4h; area under the plasma concentration curve from 0 to 4â¯h; Cmax; maximum plasma concentration; CMC; carboxymethyl cellulose; GI; gastrointestina
Keywords: ANOVA; analysis of variance; AUC0-4; area under the curve of plasma concentration versus time from 0 to 4â¯h; BA0-4; bioavailability from 0 to 4â¯h; BCS; biopharmaceutics classification system; CEL; celecoxib; Cmax; maximum plasma concentration; COX
Keywords: COPD; Budesonide; Formoterol fumarate dihydrate; Glycopyrronium; Co-suspension delivery technology; Pharmacokinetic; AE; adverse event; AUC0-â; area under the plasma concentration-time curve from time 0 to infinity; AUC0-12; area under the plasma
Keywords: SOD; superoxide dismutase; SK; streptokinase; PEG; polyethylene glycol; CAR; peptide CARSKNK; BSA; Bovine serum albumin; PVA; polyvinylalcohol; HPMC; hydroxypropyl methylcellulose; PLGA; polylactic-co-glycolic acid; HP-β-CD; hydroxypropyl-β-cyclodextrin
Keywords: Transmission; Pharmacogenomics; Incipient tuberculosis; HIV; Diabetes; Biomarkers; DAIDS; Division of AIDS; NIAID; National Institute of Allergy and Infectious Diseases; NIH; National Institutes of Health; TB; tuberculosis; RePORT; Regional Prospective Ob
Keywords: ADAM; advanced dissolution, absorption, and metabolism; AED; antiepileptic drug; AUC; area-under-the-curve; B/P; blood to plasma ratio; BID; twice daily; BMI; body mass index; CBZ; carbamazepine; CLint; intrinsic clearance; CLR; renal clearance; CL; clear
Keywords: TB; tuberculosis; HIV; human immunodeficiency virus; DPI; dry powder inhaler; AIDS; acquired immunodeficiency syndrome; WHO; world health organization; Mtb; Mycobacterium tuberculosis; AM; alveolar macrophage; PTB; pulmonary TB; EPTB; extra pulmonary TB;
Keywords: 2-AG; 2-arachidonoyl glycerol; 11-nor-THC-COOH; 11-nor-tetrahydrocannabinol-9-caboxylic acid; 11-OH-THC; 11-hydroxy-tetrahydrocannabinol; 8-OH-THC; 8-hydroxy-tetrahydrocannabinol; CB; cannabinoid; CB1R; Type I cannabinoid receptor; CB2R; Type II cannabino
Keywords: RLP; regional limb perfusion; MCP; metacarpo-phalangeal; MTP; metatarso-phalangeal; Cmax; maximum concentration; AUC; area under the curve; MRSA; methicillin resistant Staphylococcus aureus; PK; pharmacokinetics; MDR; multidrug resistant; PAE; post antibi
Keywords: MDPV; 3, 4-methylenedioxypyrovalerone; LC-MS/MS; liquid chromatography-tandem mass spectrometry; Cmax; maximal concentration; Tmax; time to maximal concentration; T1/2; elimination half-life; AUC; area under the curve; Cl; clearance; Bath salts; Pregnancy
Keywords: mIL-11; interleukin-11 mutein; PEG-mIL-11; PEGylated mIL-11; mPEG-SC; methoxy polyethylene glycol succinimidyl carbonate; AUC; area-under-the curve; Cmax; maximum plasma concentration; G-CSF; , granulocyte colony stimulating factor; EPO; erythropoietin; I
Keywords: Maximum tolerated dose; Chronic toxicity; Carcinogenicity; Toxicokinetics; Gender difference; ADME; absorption, distribution, metabolism, and excretion; AUCs; areas under the curve; Cmax; maximum concentration; KMD; kinetically-derived maximum dose; MTD;
Keywords: ALT; alanine aminotransferase; AST; aspartate aminotransferase; AUC; area under the plasma concentration-time curve; BMI; body mass index (BMI); Cmax; maximum plasma concentration; CRPus; ultrasensitive C-reactive protein; GGT; gamma-glutamyl transferas
Keywords: AUC; Area Under the Curve; API; Active Pharmaceutical Ingredient; Cmax; Maximum blood concentration; COPD; Chronic Obstructive Pulmonary Disease; DNX; Danirixin; HPLC; High Performance Liquid Chromatography; FaSSIF; Fasted State Simulated Intestinal Fluid
Pharmacokinetics, tissue distribution and excretion of luteolin and its major metabolites in rats: Metabolites predominate in blood, tissues and are mainly excreted via bile
Keywords: Luteolin; Metabolite; Pharmacokinetics; Bioavailability; Distribution; Excretion; ADME; absorption, distribution, metabolism and excretion; AUC; area under the curve; BCRP; breast cancer resistance protein; CE; collision energy; Cmax; peak concentration;
Keywords: Cmax; extrapolated maximum concentration immediately after the end of the infusion; Cmin; extrapolated minimum concentration immediately after the end of the infusion; Cl; clearance (L/h); CrCl; creatinine clearance; GFR; glomerular filtration rate; T1/2;
Keywords: cmax; maximal blood concentration; dpm; dips per minute; HPLC; High Performance Liquid Chromatography; MCT; medium-chain triglycerides; MRI; Magnetic Resonance Imaging; MV; mean value; MWCO; Molecular Weight Cut Off; PBS; phosphate buffer saline; Ph. Eur.
Keywords: ANOVA; analysis of variance; AUC(0ââ); area under plasma concentration-time curve extrapolated to infinity; Cmax; peak plasma concentration; D.E.(0-30); dissolution efficiency (0-30âmin); DMSO; dimethyl sulphoxide; DSC; differential scanning cal
Keywords: Hereditary angioedema; Bradykinin; C1 inhibitor deficiency; Bradykinin B2 receptor antagonist; Icatibant; Children; Adolescents; Pediatrics; Treatment; AE; adverse event; C1-INH; C1 inhibitor; C1-INH-HAE; hereditary angioedema with C1-inhibitor deficiency
Keywords: Cmax; maximum concentration measured; AUC; area under the curve of concentration to time profile; Liposome; Doxorubicin; Tissue distribution; Drug delivery;
Keywords: MMC; Migrating Motor Complex; TIM; TNO Intestinal Model; Fmoc-Cl; 9-fluorenylmethoxy-carbonyl chloride; Cmax; Maximal drug concentration; fsim; average similarity factor; MRI; Magnetic Resonance Imaging; Gastrointestinal; Motility; Oral drug delivery; Dru
Keywords: AST; aspartate transaminase; BSA; bovine serum albumin; Cmax; maximal plasma concentration; DILI; drug-induced liver injury; EC50; half maximal effective concentration; GLDH; glutamate dehydrogenase; KH; Krebs-Henseleit; LDH; lactate dehydrogenase; NL; no
Keywords: Alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS, PubChem CID:71406); Cisplatin (PubChem CID:441203); Distearoyl phosphoethanolamine polyethylene glycol 2000, sodium salt (DSPE-mPEG-2000, PubChem CID:86278270); l-leucine (PubChem CID: 6106); d-ma
Keywords: biliary excretion; drug interactions; efflux pumps; MRP; permeability; ATV; atorvastatin; MET; metformin; 2-OH ATV; 2-hydroxyatorvastatin; CYP; cytochrome P450; MDCK; Madin-Darby canine kidney; MDR; multidrug resistance gene; BCRP; breast cancer resistanc
Keywords: SACP; simulated annealing of chemical potential; CFA; constrained fragment analysis; FE Pred; predicted relative free energy; ÎÎGs; relative solvation change; D5W; 5% dextrose (glucose) in water; Vdss; steady-state volume of distribution; Cl; clearance;
Keywords: salt; solubility; pH; dissolution; poorly water soluble; solution phase; solid phase; equilibrium; salt dissociation; phase-transformation; API; active pharmaceutical ingredient; AUC; area under curve; Cmax; maximum concentration; FaSSIF; fasted state sim
Keywords: ADME; absorption, distribution, metabolism, and excretion; AUC; area under concentration-time curve; BCRP; breast cancer resistance protein; BSEP; bile salt export pump; CFTR; cystic fibrosis transmembrane conductance regulator; Cmax; maximal plasma conce
Keywords: AUC24; area under the concentration time curve in 24Â h; CL; clearance; Cmax; maximum concentration; Cmin; minimum concentration; FN; febrile neutropenia; Ke; elimination rate-constant; MIC; minimal inhibitory concentration; SD; standard deviation; t1/2;
Keywords: PLGA; poly (lactic-co-glycolic acid); PEG; polyethylene glycol; MS; spherical microparticles; NM; nanostructured microparticles; PLGA MS; spherical microparticles without mucoadhesion; PLGA/PEG MS; spherical microparticles with mucoadhesion; PLGA NM; nano
Keywords: Piperazine derivatives; MTT assay; α1A blocking activity; Pharmacokinetics; BPH; Benign prostatic hyperplasia; T; testosterone; DHT; dihydrotestosterone; SARM; selective androgen receptor modulator; PSA; prostate specific antigen; MTT; 3-(4, 5-dimethylth
Keywords: Antibiotic drug resistance; Caenorhabditis elegans; Methicillin-resistant Staphylococcus aureus; MRSA; Intracellular infection; Pharmacokinetics; AMR; Antimicrobial resistance; Caco-2; heterogeneous human epithelial colorectal adenocarcinoma cells; CFUs;
Keywords: AE; Apple extract; AE+BE; Apple and blackcurrant extracts; iAUC; Incremental area under the curve; Cmax; Maximum concentration; CON; Control treatment; DVP-SI; Digital volume pulse stiffness index; DVP-RI; Digital volume pulse reflection index; GIP; Gluco
Keywords: physiologically based pharmacokinetic modeling; transporters; hepatobiliary disposition; hepatic metabolism; mathematical model; AUC; area under the concentration-time curve; Cmax; maximum plasma concentration; CYP; cytochrome P450 enzyme; CL; clearance;
Keywords: Cough; Carcainium chloride; Antitussive; Idiopathic interstitial pneumonia; Cph; coughs per hour; IIP; idiopathic interstitial pneumonia; Cmax; maximum plasma concentration; Tmax; time to reach maximum plasma concentration; VAS; visual analogue scale;
Keywords: Natural products; Dietary supplements; Herbal medicines; Drug interactions; Cytochrome P450; Transporters; Metabolic enzymes; CYP450; cytochrome P450; Cmax; maximum concentration; DDI; drug-drug interactions; MDP; methylenedioxyphenyl; NP; natural produ
Keywords: ANOVA; analysis of variance; AUC0â¿¿24; area under the curve of blood concentration vs. time from tâ¿¿=â¿¿0 to tâ¿¿=â¿¿24 after oral administration; BA; oral bioavailability; Cmax; maximum concentration; CWM; cold wet-milling; CoQ10; coenzyme Q10; DSC; di
Keywords: LS; lauryl sulfate; SLS; sodium lauryl sulfate; SEM; scanning electron microscopy; SD; standard deviation; Cmax; maximum concentration; tmax; time to reach Cmax; AUC; area under the curve; Sustained-release; Suspension; Lauryl sulfate; Salt; Complex; Spra